Glaukos Pre-Tax Income 2014-2024 | GKOS
Glaukos pre-tax income from 2014 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
| Glaukos Annual Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024 | $-146 |
| 2023 | $-134 |
| 2022 | $-98 |
| 2021 | $-49 |
| 2020 | $-132 |
| 2019 | $-50 |
| 2018 | $-12 |
| 2017 | $0 |
| 2016 | $5 |
| 2015 | $-38 |
| 2014 | $-14 |
| 2013 | $-14 |
| Glaukos Quarterly Pre-Tax Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-34 |
| 2024-09-30 | $-21 |
| 2024-06-30 | $-50 |
| 2024-03-31 | $-40 |
| 2023-12-31 | $-37 |
| 2023-09-30 | $-30 |
| 2023-06-30 | $-32 |
| 2023-03-31 | $-34 |
| 2022-12-31 | $-31 |
| 2022-09-30 | $-27 |
| 2022-06-30 | $-46 |
| 2022-03-31 | $6 |
| 2021-12-31 | $-22 |
| 2021-09-30 | $6 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-16 |
| 2020-12-31 | $-14 |
| 2020-09-30 | $-17 |
| 2020-06-30 | $-47 |
| 2020-03-31 | $-55 |
| 2019-12-31 | $-29 |
| 2019-09-30 | $-13 |
| 2019-06-30 | $-6 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $2 |
| 2018-09-30 | $-7 |
| 2018-06-30 | $-5 |
| 2018-03-31 | $-3 |
| 2017-12-31 | $1 |
| 2017-09-30 | $1 |
| 2017-06-30 | $-3 |
| 2017-03-31 | $1 |
| 2016-12-31 | $0 |
| 2016-09-30 | $1 |
| 2016-06-30 | $2 |
| 2016-03-31 | $1 |
| 2015-12-31 | $-2 |
| 2015-09-30 | $-2 |
| 2015-06-30 | $-33 |
| 2015-03-31 | $-1 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-2 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $-4 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $4.769B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||